Immix Biopharma (IMMX) Prepaid Assets (2020 - 2026)
Immix Biopharma (IMMX) reported Prepaid Assets of $335739.0 for Q1 2026, up 98.56% on a YoY basis from $169087.0 in Q1 2025, and up 86.62% sequentially from $179903.0 in Q4 2025.
Immix Biopharma (IMMX) Prepaid Assets (2020 - 2026) Analysis & Trends
Immix Biopharma (IMMX) has 7 years of Prepaid Assets data on file, last reported at $335739.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 98.56% year-over-year to $335739.0; the trailing twelve-month figure through Mar 2026 stood at $335739.0 (up 98.56% YoY), and the FY2025 full-year result was $179903.0, up 1827.39% from the prior year.
- Prepaid Assets improved to $335739.0 in Q1 2026, from $179903.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.6 million in Q2 2023 to a low of $9334.0 in Q4 2024.
- A 5-year average of $573217.2 and a median of $263927.0 in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets sank 98.26% in 2024 and jumped 1827.39% in 2025, its largest moves.
- Tracing IMMX's Prepaid Assets over 5 years: stood at $78067.0 in 2022, then soared by 238.08% to $263927.0 in 2023, then slumped by 96.46% to $9334.0 in 2024, then jumped by 1827.39% to $179903.0 in 2025, then soared by 86.62% to $335739.0 in 2026.
- Business Quant data shows IMMX's Prepaid Assets at $335739.0 in Q1 2026, $179903.0 in Q4 2025, and $49647.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immix Biopharma | 487.25 Mn | 487.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 335,739.00 |
| Dec 31, 2025 | 179,903.00 |
| Sep 30, 2025 | 49,647.00 |
| Jun 30, 2025 | 687,515.00 |
| Mar 31, 2025 | 169,087.00 |
| Dec 31, 2024 | 9,334.00 |
| Sep 30, 2024 | 36,521.00 |
| Jun 30, 2024 | 149,835.00 |
| Mar 31, 2024 | 187,985.00 |
| Dec 31, 2023 | 263,927.00 |
| Sep 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | 2.56 Mn |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | 78,067.00 |
| Sep 30, 2022 | 292,047.00 |
| Jun 30, 2022 | 515,948.00 |
| Mar 31, 2022 | 888,014.00 |
| Dec 31, 2021 | 516,193.00 |
| Dec 31, 2020 | 13,714.00 |